Toxicity of an Fc engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable anti-tumor immunity in patients Meeting Abstract


Authors: Knorr, D.; Ravetch, J.; D'Andrea, G.; Vahdat, L.; Klebanoff, C.; Robson, M.
Abstract Title: Toxicity of an Fc engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable anti-tumor immunity in patients
Meeting Title: 36th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2021)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 9
Issue: Suppl. 2
Meeting Dates: 2021 Nov 10-14
Meeting Location: Washington, DC
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2021-11-01
Start Page: A528
Language: English
ACCESSION: WOS:000774877500477
DOI: 10.1136/jitc-2021-SITC2021.496
PROVIDER: wos
Notes: Meeting Abstract: 496 -- Meeting was also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark E Robson
    676 Robson
  2. Linda T Vahdat
    43 Vahdat